Correction to: npj Vaccines https://doi.org/10.1038/s41541-016-0003-3, published online 23 January 2017
The original version of the Article contained errors in the display of the labels in Fig. 6b. These errors have now been corrected in the HTML and PDF versions of the paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41541-016-0003-3.
The original article can be found online at https://doi.org/10.1038/s41541-016-0003-3.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, M., Zuest, R., Velumani, S. et al. Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus. npj Vaccines 3, 7 (2018). https://doi.org/10.1038/s41541-018-0044-x
Published:
DOI: https://doi.org/10.1038/s41541-018-0044-x
